Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C.
Ahlenstiel G, Berg T, Woitas RP, Grünhage F, Iwan A, Hess L, Brackmann HH, Kupfer B, Schernick A, Sauerbruch T, Spengler U.
Ahlenstiel G, et al. Among authors: kupfer b.
J Hepatol. 2003 Aug;39(2):245-52. doi: 10.1016/s0168-8278(03)00193-4.
J Hepatol. 2003.
PMID: 12873822